ZIMV logo

ZimVie (ZIMV) Company Overview

Profile

Full Name:

ZimVie Inc.

Sector:

Healthcare

Country:

United States

IPO:

February 16, 2022

Indexes:

Not included

Description:

ZimVie is a global company that focuses on developing and providing innovative solutions in the dental and spine markets. They create products that help improve patient outcomes and support healthcare professionals in delivering effective treatments. ZimVie aims to enhance quality of life through advanced medical technologies.

Key Details

Price

$13.46

Annual Revenue

$457.43 M(-1.26% YoY)

Annual EPS

-$14.87(-506.94% YoY)

Annual ROE

-67.34%

Beta

1.27

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 2, 24 Needham
Buy
Jun 25, 24 Needham
Buy
May 16, 24 Needham
Buy
May 9, 24 Needham
Hold
Apr 11, 24 Needham
Hold
Mar 5, 24 Barclays
Underweight
Jan 4, 24 Barclays
Underweight
Dec 20, 23 JP Morgan
Neutral
Nov 16, 23 Needham
Hold
Nov 2, 23 JP Morgan
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Zimvie (ZIMV) Slid on Acquisition Rumors
Zimvie (ZIMV) Slid on Acquisition Rumors
Zimvie (ZIMV) Slid on Acquisition Rumors
ZIMV
Insider MonkeyJanuary 31, 2025

Summers Value Partners, an investment management firm, has published its investor letter for the fourth quarter of 2024, which you can download here. The Summers Value Fund LP achieved a net return of 27.4% in 2024, surpassing the 11.3% return of its main benchmark, the Russell 2000 Index ETF (IWM). Additionally, the fund also did better than its secondary benchmark.

ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
ZIMV
seekingalpha.comOctober 30, 2024

ZimVie Inc. (NASDAQ:ZIMV ) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Marissa Bych Thank you all for joining today's call. Earlier today, ZimVie released financial results for the quarter ended September 30, 2024.

Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
ZIMV
globenewswire.comOctober 2, 2024

Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Mexico Spinal Implants Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Cervical Fixation Market, Thoracolumbar Fixation Market, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, Mexico's spinal implant and VCF market reached a valuation exceeding $135 million. Projected to grow at a CAGR of 6.1%, the market is expected to surpass $205 million by 2030. This comprehensive report on the Mexican spinal implant and VCF market covers various segments, including traditional cervical and thoracolumbar fixation devices, interbody devices, motion preservation devices, VCF treatment, electrical stimulation devices, and spinal surgery instrumentation. Key Market Data Insights:

ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript
ZIMV
seekingalpha.comAugust 4, 2024

ZimVie Inc. (NASDAQ:ZIMV ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 AM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Operator Good afternoon, and welcome to ZimVie's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
ZIMV
globenewswire.comJuly 23, 2024

Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings

ZimVie to Report Second Quarter Financial Results on August 1, 2024
ZimVie to Report Second Quarter Financial Results on August 1, 2024
ZimVie to Report Second Quarter Financial Results on August 1, 2024
ZIMV
globenewswire.comJuly 18, 2024

PALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024 after market close on Thursday, August 1, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

ZimVie to Participate in Upcoming Investor Conferences
ZimVie to Participate in Upcoming Investor Conferences
ZimVie to Participate in Upcoming Investor Conferences
ZIMV
globenewswire.comMay 16, 2024

ZimVie Inc., a global leader in the dental market, has announced its participation in two upcoming investor conferences.

ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript
ZIMV
Seeking AlphaFebruary 28, 2024

ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript

ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade)
ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade)
ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade)
ZIMV
Seeking AlphaDecember 26, 2023

ZimVie's stock has doubled since reporting Q3 earnings, causing investors to wonder about the company's future. The company's Q3 revenues declined less than expected and the company raised full-year guidance. More importantly, ZimVie's decision to sell its spine business for $375 million jettisons an underperforming segment while solving a debt overhang.

ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript
ZIMV
Seeking AlphaNovember 1, 2023

ZimVie Inc. (NASDAQ:ZIMV ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Vafa Jamali - President and Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants Lilly Wyttenbach - JPMorgan Matt Miksic - Barclays Operator Good day, and thank you for standing by. Welcome to the ZimVie Third Quarter 2023 Financial Results Conference Call.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the ticker symbol for ZimVie?
  • Does ZimVie pay dividends?
  • What sector is ZimVie in?
  • What industry is ZimVie in?
  • What country is ZimVie based in?
  • When did ZimVie go public?
  • Is ZimVie in the S&P 500?
  • Is ZimVie in the NASDAQ 100?
  • Is ZimVie in the Dow Jones?
  • When was ZimVie's last earnings report?
  • When does ZimVie report earnings?
  • Should I buy ZimVie stock now?

What is the ticker symbol for ZimVie?

The ticker symbol for ZimVie is NASDAQ:ZIMV

Does ZimVie pay dividends?

No, ZimVie does not pay dividends

What sector is ZimVie in?

ZimVie is in the Healthcare sector

What industry is ZimVie in?

ZimVie is in the Medical Devices industry

What country is ZimVie based in?

ZimVie is headquartered in United States

When did ZimVie go public?

ZimVie's initial public offering (IPO) was on February 16, 2022

Is ZimVie in the S&P 500?

No, ZimVie is not included in the S&P 500 index

Is ZimVie in the NASDAQ 100?

No, ZimVie is not included in the NASDAQ 100 index

Is ZimVie in the Dow Jones?

No, ZimVie is not included in the Dow Jones index

When was ZimVie's last earnings report?

ZimVie's most recent earnings report was on Oct 30, 2024

When does ZimVie report earnings?

The next expected earnings date for ZimVie is Feb 28, 2025

Should I buy ZimVie stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions